• Je něco špatně v tomto záznamu ?

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

JS. Healey, J. Oldgren, M. Ezekowitz, J. Zhu, P. Pais, J. Wang, P. Commerford, P. Jansky, A. Avezum, A. Sigamani, A. Demasceno, P. Reilly, A. Grinvalds, J. Nakamya, A. Aje, W. Almahmeed, A. Moriarty, L. Wallentin, S. Yusuf, SJ. Connolly, . ,

. 2016 ; 388 (10050) : 1161-9. [pub] 20160808

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000233
E-zdroje Online Plný text

NLK ProQuest Central od 1992-01-04 do Před 3 měsíci
Nursing & Allied Health Database (ProQuest) od 1992-01-04 do Před 3 měsíci
Health & Medicine (ProQuest) od 1992-01-04 do Před 3 měsíci
Family Health Database (ProQuest) od 1992-01-04 do Před 3 měsíci
Psychology Database (ProQuest) od 1992-01-04 do Před 3 měsíci
Health Management Database (ProQuest) od 1992-01-04 do Před 3 měsíci
Public Health Database (ProQuest) od 1992-01-04 do Před 3 měsíci

Odkazy

PubMed 27515684
DOI 10.1016/s0140-6736(16)30968-0
Knihovny.cz E-zdroje

BACKGROUND: Atrial fibrillation is an important cause of morbidity and mortality worldwide, but scant data are available for long-term outcomes in individuals outside North America or Europe, especially in primary care settings. METHODS: We did a cohort study using a prospective registry of patients in 47 countries who presented to a hospital emergency department with atrial fibrillation or atrial flutter as a primary or secondary diagnosis. 15 400 individuals were enrolled to determine the occurrence of death and strokes (the primary outcomes) in this cohort over eight geographical regions (North America, western Europe, and Australia; South America; eastern Europe; the Middle East and Mediterranean crescent; sub-Saharan Africa; India; China; and southeast Asia) 1 year after attending the emergency department. Patients from North America, western Europe, and Australia were used as the reference population, and compared with patients from the other seven regions FINDINGS: Between Dec 24, 2007, and Oct 21, 2011, we enrolled 15 400 individuals to the registry. Follow-up was complete for 15 361 (99·7%), of whom 1758 (11%) died within 1 year. Fewer deaths occurred among patients presenting to the emergency department with a primary diagnosis of atrial fibrillation compared with patients who had atrial fibrillation as a secondary diagnosis (377 [6%] of 6825 patients vs 1381 [16%] of 8536, p<0·0001). Twice as many patients had died by 1 year in South America (192 [17%] of 1132) and Africa (225 [20%] of 1137) compared with North America, western Europe, and Australia (366 [10%] of 3800, p<0·0001). Heart failure was the most common cause of death (519 [30%] of 1758); stroke caused 148 (8%) deaths. 604 (4%) of 15361 patients had had a stroke by 1 year; 170 (3%) of 6825 for whom atrial fibrillation was a primary diagnosis and 434 (5%) of 8536 for whom it was a secondary diagnosis (p<0·0001). The highest number of strokes occurred in patients in Africa (89 [8%] of 1137), China (143 [7%] of 2023), and southeast Asia (88 [7%] of 1331) and the lowest occurred in India (20 [<1%] of 2536). 94 (3%) of 3800 patients in North America, western Europe, and Australia had a stroke. INTERPRETATION: Marked unexplained inter-regional variations in the occurrence of stroke and mortality suggest that factors other than clinical variables might be important. Prevention of death from heart failure should be a major priority in the treatment of atrial fibrillation. FUNDING: Boehringer Ingelheim.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000233
003      
CZ-PrNML
005      
20170120095657.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/S0140-6736(16)30968-0 $2 doi
024    7_
$a 10.1016/S0140-6736(16)30968-0 $2 doi
035    __
$a (PubMed)27515684
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Healey, Jeff S $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada. Electronic address: Jeff.Healey@phri.ca.
245    10
$a Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study / $c JS. Healey, J. Oldgren, M. Ezekowitz, J. Zhu, P. Pais, J. Wang, P. Commerford, P. Jansky, A. Avezum, A. Sigamani, A. Demasceno, P. Reilly, A. Grinvalds, J. Nakamya, A. Aje, W. Almahmeed, A. Moriarty, L. Wallentin, S. Yusuf, SJ. Connolly, . ,
520    9_
$a BACKGROUND: Atrial fibrillation is an important cause of morbidity and mortality worldwide, but scant data are available for long-term outcomes in individuals outside North America or Europe, especially in primary care settings. METHODS: We did a cohort study using a prospective registry of patients in 47 countries who presented to a hospital emergency department with atrial fibrillation or atrial flutter as a primary or secondary diagnosis. 15 400 individuals were enrolled to determine the occurrence of death and strokes (the primary outcomes) in this cohort over eight geographical regions (North America, western Europe, and Australia; South America; eastern Europe; the Middle East and Mediterranean crescent; sub-Saharan Africa; India; China; and southeast Asia) 1 year after attending the emergency department. Patients from North America, western Europe, and Australia were used as the reference population, and compared with patients from the other seven regions FINDINGS: Between Dec 24, 2007, and Oct 21, 2011, we enrolled 15 400 individuals to the registry. Follow-up was complete for 15 361 (99·7%), of whom 1758 (11%) died within 1 year. Fewer deaths occurred among patients presenting to the emergency department with a primary diagnosis of atrial fibrillation compared with patients who had atrial fibrillation as a secondary diagnosis (377 [6%] of 6825 patients vs 1381 [16%] of 8536, p<0·0001). Twice as many patients had died by 1 year in South America (192 [17%] of 1132) and Africa (225 [20%] of 1137) compared with North America, western Europe, and Australia (366 [10%] of 3800, p<0·0001). Heart failure was the most common cause of death (519 [30%] of 1758); stroke caused 148 (8%) deaths. 604 (4%) of 15361 patients had had a stroke by 1 year; 170 (3%) of 6825 for whom atrial fibrillation was a primary diagnosis and 434 (5%) of 8536 for whom it was a secondary diagnosis (p<0·0001). The highest number of strokes occurred in patients in Africa (89 [8%] of 1137), China (143 [7%] of 2023), and southeast Asia (88 [7%] of 1331) and the lowest occurred in India (20 [<1%] of 2536). 94 (3%) of 3800 patients in North America, western Europe, and Australia had a stroke. INTERPRETATION: Marked unexplained inter-regional variations in the occurrence of stroke and mortality suggest that factors other than clinical variables might be important. Prevention of death from heart failure should be a major priority in the treatment of atrial fibrillation. FUNDING: Boehringer Ingelheim.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x komplikace $x diagnóza $x epidemiologie $7 D001281
650    _2
$a kohortové studie $7 D015331
650    _2
$a komorbidita $7 D015897
650    12
$a smrt $7 D003643
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a celosvětové zdraví $7 D014943
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a cévní mozková příhoda $x epidemiologie $x etiologie $x mortalita $7 D020521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Oldgren, Jonas $u Uppsala Clinical Research, Uppsala, Sweden.
700    1_
$a Ezekowitz, Michael $u Lankenau Institute for Medical Research, Wynnewood, PA, USA.
700    1_
$a Zhu, Jun $u Fuwai Hospital CAMS and PUMC, Beijing, China.
700    1_
$a Pais, Prem $u St John's Medical College and Bangalore Research Institute, Bangalore, India.
700    1_
$a Wang, Jia $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Commerford, Patrick $u Department of Medicine, University of Cape Town, Cape Town, South Africa.
700    1_
$a Jansky, Petr $u University Hospital Motol, Prague, Czech Republic.
700    1_
$a Avezum, Alvaro $u Instituto Dante Pazzanesse de Cardiologia, Sao Paulo, Brazil. $7 gn_A_00010338
700    1_
$a Sigamani, Alben $u St John's Medical College and Bangalore Research Institute, Bangalore, India.
700    1_
$a Demasceno, Albertino $u Eduardo Mondlane University, Maputo, Mozambique.
700    1_
$a Reilly, Paul $u Boehringer Ingelheim, Bieberach, Germany.
700    1_
$a Grinvalds, Alex $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Nakamya, Juliet $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Aje, Akinyemi $u University College Hospital, Ibadan, Nigeria. $7 gn_A_00002779
700    1_
$a Almahmeed, Wael $u Sheikh Khalifa Medical City and Cleveland Clinic, Abu Dhabi, United Arab Emirates. $7 gn_A_00004571
700    1_
$a Moriarty, Andrew $u Craigavon Area Hospital, Craigavon, County Armagh, UK.
700    1_
$a Wallentin, Lars $u Uppsala Clinical Research, Uppsala, Sweden.
700    1_
$a Yusuf, Salim $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Connolly, Stuart J $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a ,
773    0_
$w MED00010161 $t Lancet (London, England) $x 1474-547X $g Roč. 388, č. 10050 (2016), s. 1161-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27515684 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170120095806 $b ABA008
999    __
$a ok $b bmc $g 1179373 $s 960800
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 388 $c 10050 $d 1161-9 $e 20160808 $i 1474-547X $m Lancet $n Lancet $x MED00010161
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

    Možnosti archivace